COVID-19-related excess mortality – an overview of the current evidence

Author:

Zińczuk Aleksander1,Rorat Marta1,Jurek Tomasz1ORCID

Affiliation:

1. Department of Forensic Medicine, Wroclaw Medical University, Poland

Abstract

Analysis of excess deaths, defined as the difference in the total number of deaths in an emergency compared to the number of deaths expected under normal conditions, allows a more reliable assessment of the impact on health systems caused by the global threat of SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2). So far, data for the two years of the pandemic (2020-2021) indicates the occurrence of 14.9 million excess deaths according to WHO (World Health Organization) estimates. The purpose of the analysis conducted was to define the concept and identify the causes of excess mortality during the COVID-19 pandemic. Inconsistent and unreliable death registration systems; overburdened health systems in low- and middle-income countries; reduced access to medical services for patients with health problems other than COVID-19; the introduction of social distancing and lockdown rules, which translated into increased deaths from psychiatric illnesses and addictions; political considerations and media messages that interfered with vaccination acceptance and adherence; and the additional impact of other natural disasters (hurricanes, floods, drought) were identified as the most important reasons for excess deaths occurrence. The correct identification of country-specific factors and the correct response and countermeasures taken appear crucial in terms of limiting the negative impact of the current pandemic, but also of future threats of a similar nature, in order to reduce excess deaths.

Publisher

Uniwersytet Jagiellonski - Wydawnictwo Uniwersytetu Jagiellonskiego

Subject

General Medicine

Reference116 articles.

1. 1. "Pneumonia of unknown cause - China." https://www.who.int/emergencies/disease-outbreak-news/item/2020-DON229 (accessed May 11, 2023).

2. 2. "Archived: WHO Timeline - COVID-19." https://www.who.int/news/item/27-04-2020-who-timeline---covid-19 (accessed May 11, 2023).

3. 3. "Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)." https://www.who.int/news/item/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov) (accessed May 11, 2023).

4. 4. X. W. Bian, "Autopsy of COVID-19 patients in China," Natl Sci Rev, vol. 7, no. 9, pp. 1414-1418, Sep. 2020, doi: 10.1093/NSR/NWAA123.

5. 5. R. G. Menezes, T. Rizwan, S. S. Ali, W.Hassan et al., "Postmortem findings in COVID-19 fatalities: A systematic review of current evidence," Leg Med (Tokyo), vol. 54, p. 102001, Feb. 2022, doi: 10.1016/J.LEGALMED.2021.102001.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3